Literature DB >> 17926519

[Prevalence and incidence of NSAID-induced gastrointestinal ulcers and bleeding].

Michiko Yamagata1, Hideyuki Hiraishi.   

Abstract

Helicobacter pylori infection and non-steroidal anti-inflammatory drugs (NSAID) have been accepted as major causes of upper gastrointestinal (GI) ulcers and bleeding. As patients with Helicobacter pylori infection have decreased, upper GI disorders related to NSAID have been relatively increasing. Among patients taking low-dose aspirin, the prevalence of upper GI ulcers is 10-40% and aspirin increases the risk of upper GI bleeding up to 2-fold. Among patients taking nonaspirin NSAID, the prevalence of upper GI ulcers is around 20% and nonaspirin NSAID increases the risk of upper GI bleeding up to 4- to 6-fold. Since the prevalence of GI disorders related to NSAID is very high, endoscopic examination might be considered to monitor GI lesions for patients taking NSAID.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17926519

Source DB:  PubMed          Journal:  Nihon Rinsho        ISSN: 0047-1852


  2 in total

Review 1.  Gut homeostasis, injury, and healing: New therapeutic targets.

Authors:  Sema Oncel; Marc D Basson
Journal:  World J Gastroenterol       Date:  2022-05-07       Impact factor: 5.374

Review 2.  ANTI-ULCEROGENIC EFFICACY AND MECHANISMS OF EDIBLE AND NATURAL INGREDIENTS IN NSAID-INDUCED ANIMAL MODELS.

Authors:  Weiping Bi; Lizhi Hu; Mao-Qiang Man
Journal:  Afr J Tradit Complement Altern Med       Date:  2017-06-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.